Design Therapeutics, Inc.
Nasdaq DSGN · Carlsbad, CA
Works in Genetic & rare · Metabolic & endocrine · Neurology · Ophthalmology
Design Therapeutics, Inc. is a clinical trial sponsor based in Carlsbad, CA, listed as Nasdaq DSGN. It has 3 active clinical trials with 126 planned participants, in Genetic & rare, Metabolic & endocrine, Neurology and Ophthalmology. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq DSGN
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Design Therapeutics, Inc
Design Therapeutics, Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 126 planned participants, in Genetic & rare, Metabolic & endocrine, Neurology, Ophthalmology. Since 2021 it has completed 2 trials and stopped 0 early.
Design Therapeutics, Inc is based in Carlsbad, CA and is listed as Nasdaq DSGN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Design Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-28.
Approve Suite is not affiliated with Design Therapeutics, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.